Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N(2)M(2) umbrella trial.
- DOI
- 10.1038/s41591-025-03928-9
- Published
- 2025 Oct
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-025-03928-9,
title = {Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N(2)M(2) umbrella trial.},
author = {Wick W and Lanz LM and Wick A and Harting I and Dettmer S and Suwala AK and Ketter R and Tabatabai G and Seliger C and Glas M and Burger MC and Timmer M and Ringel FA and Mildenberger I and Schulz-Schaeffer WJ and Winkler F and König L and Herold-Mende C and Eisenmenger A and Pfister SM and Renovanz M and Bendszus M and Sahm F and Platten M and Kessler T},
year = {2025},
journal = {Nature medicine},
doi = {10.1038/s41591-025-03928-9},
url = {https://doi.org/10.1038/s41591-025-03928-9}
}RIS
TY - JOUR TI - Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N(2)M(2) umbrella trial. AU - Wick W AU - Lanz LM AU - Wick A AU - Harting I AU - Dettmer S AU - Suwala AK AU - Ketter R AU - Tabatabai G AU - Seliger C AU - Glas M AU - Burger MC AU - Timmer M AU - Ringel FA AU - Mildenberger I AU - Schulz-Schaeffer WJ AU - Winkler F AU - König L AU - Herold-Mende C AU - Eisenmenger A AU - Pfister SM AU - Renovanz M AU - Bendszus M AU - Sahm F AU - Platten M AU - Kessler T PY - 2025 JO - Nature medicine DO - 10.1038/s41591-025-03928-9 UR - https://doi.org/10.1038/s41591-025-03928-9 ER -
APA
W, W., LM, L., A, W., I, H., S, D., AK, S., R, K., G, T., C, S., M, G., MC, B., M, T., FA, R., I, M., WJ, S., F, W., L, K., C, H., A, E., SM, P., M, R., M, B., F, S., M, P., & T, K. (2025). Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N(2)M(2) umbrella trial.. Nature medicine. https://doi.org/10.1038/s41591-025-03928-9
Source records
- pubmed · retrieved 2026-09-25T22:01:56.581Z